Skip to main content
OpenTrials

Clinical trial condition

Plaque-type Psoriasis

Explore clinical trials studying Plaque-type Psoriasis. Study availability and eligibility vary by location and protocol.

10 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Plaque-type Psoriasis trial results

Completed

Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)

NCT00773734

Conditions
Plaque-type Psoriasis, Psoriasis, Skin Diseases, +2 more
Locations
  • Associates In Research Inc Fresno, California, United States
  • Dermatology Associates Los Angeles, California, United States
  • Stanford University School of Medicine Redwood City, California, United States
  • Atlantic Skin & Cosmetic Surgery Group, PC Wilmington, Delaware, United States
View all 35 locations
View Trial Details
Completed

Apremilast Safety and PK Study in Recalcitrant Plaque Psoriasis

NCT00521339

Conditions
Plaque-type Psoriasis, Psoriasis, Psoriasis-Type Psoriasis, +3 more
Locations
  • Tufts-New England Medical Center Hospitals Boston, Massachusetts, United States
  • Central Dermatology St Louis, Missouri, United States
  • Oregon Medical Research Center, P.C. Portland, Oregon, United States
  • Baylor Research Institute Dallas, Texas, United States
View Trial Details
Completed

Judging the Efficacy of Secukinumab in Patients With Psoriasis Using AutoiNjector: a Clinical Trial Evaluating Treatment Results (JUNCTURE)

NCT01636687

Conditions
Disease Attributes, Pathologic Processes, Pathological Conditions, Anatomical, +11 more
Locations
  • Novartis Investigative Site Phoenix, Arizona, United States
  • Novartis Investigative Site Los Angeles, California, United States
  • Novartis Investigative Site Oceanside, California, United States
  • Novartis Investigative Site Overland Park, Kansas, United States
View all 39 locations
View Trial Details
Completed

AIN457 Regimen Finding Extension Study in Participants With Moderate to Severe Psoriasis

NCT01132612

Conditions
Plaque-type Psoriasis
Locations
  • Novartis Investigative Site Birmingham, Alabama, United States
  • Novartis Investigative Site Little Rock, Arkansas, United States
  • Novartis Investigative Site Pasadena, California, United States
  • Novartis Investigative Site San Diego, California, United States
View all 57 locations
View Trial Details
Completed

Efficacy and Safety of Intravenous and Subcutaneous Secukinumab in Moderate to Severe Chronic Plaque-type Psoriasis

NCT01412944

Conditions
Dermatitis, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, +6 more
Locations
  • Novartis Investigative Site Jacksonville, Florida, United States
  • Novartis Investigative Site West Palm Beach, Florida, United States
  • Novartis Investigative Site Boston, Massachusetts, United States
  • Novartis Investigative Site St Louis, Missouri, United States
View all 27 locations
View Trial Details
Completed

Study of Dose-Effect of COL-121 Ointment in Patients With Plaque-Type Psoriasis

NCT00625326

Conditions
Plaque-type Psoriasis, Psoriasis, Skin Diseases, +2 more
Locations
  • East Bay Dermatology Medical Group Fremont, California, United States
  • Dermatology Research Associates Los Angeles, California, United States
  • Skin Surgery Medical Group, Inc. San Diego, California, United States
  • Dermatology Specialists, Inc. Vista, California, United States
View all 20 locations
View Trial Details

Related conditions